United States · 
Who invested in PhaseBio?
PhaseBio's investors include New Enterprise Associates, Hatteras Venture Partners, AstraZeneca, Syno Capital and Fletcher Spaght, and 6 more on record.
2018
$16MRound$34MSeries DUnited States · Series D startup
Who invested in PhaseBio
2 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$50Mraised across 2 rounds since 2017, from 2 sources
$16MRound$34MSeries D
- Latest round
- Series D, $34MSept 2018
- Step-upi
- 2.2×
- Investors
- 11
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $16M Nov 2017
- Biggest round
- $34M Series D · Sept 2018
- Between rounds
- 9 months from the last two
The rounds
- Sept 2018Series D$34M4 new5 returning
New Enterprise Associates
Hatteras Venture Partners
Mountain Group Partners
AstraZeneca- JJDC
Syno Capital- Fletcher Spaght
- Cormorant Asset
- Rock Springs
Reported by FinSMEs
- Nov 2017
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Fletcher SpaghtInvestment firm2rounds
Johnson & Johnson Robotics and Digital SolutionsCorporate VC1round
JJDCInvestment firm1round
Cormorant Assetno record of our own yet1round
Rock Springsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about PhaseBio
How much has PhaseBio raised?
PhaseBio has raised $50M across 2 rounds since 2017.
When did PhaseBio last raise?
PhaseBio's most recent round was a Series D of $34M in Sept 2018.
What was PhaseBio's biggest round?
Its most recent round, $34M in Sept 2018, is also its largest on record.
Who backed PhaseBio first?
PhaseBio's first round on record, in Nov 2017, was backed by New Enterprise Associates, SVB Capital and Hatteras Venture Partners and 4 others.
What stage is PhaseBio at?
PhaseBio's latest named round is a Series D, in Sept 2018.
Where is PhaseBio based?
PhaseBio is based in the United States.
Companies like PhaseBio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.